Abstract:Mouse models for human diseases have been shown to be very useful for analyzing patho-physiology of disease development and devising a new way of treatment including drug development. In this review, we will demonstrate this by two examples.Among several spontaneous mutants showing tremor, the quaking viable (qkv) mutation is an autosomal recessive mutation that exhibits pleiotropic effects on myelination and spermatogenesis (male sterility) . Homozygous mutant animals exhibit a characteristic tremor or ‘quaking’ of the hindlimbs by postnatal 10 day, and tonic type seizures at later stages. qkI, encoding an RNA binding protein, was identified as a candidate for this mutation. Through the binding to pre-mRNA, QKI may be involved in processing, localization, and protein expression of mRNA for myelin proteins. In addition, we found a novel function of qkI in smooth muscle cell (SMC) differentiation during embryonic blood vessel formation.A mouse model of Rubinstein-Taybi syndrome (RTS) was generated by an insertional mutation into the cyclic AMP response element-binding protein (CREB) -binding protein (Crebbp) gene. Heterozygous Crebbp-deficient mice, which had truncated CBP protein containing the CREB-binding domain, showed clinical features of RTS, such as growth retardation (100%), retarded osseous maturation (100%), hypoplastic maxilla with narrow palate (100%), cardiac anomalies (15%) and skeletal abnormalities (7%) . Tests for memory storage such as the step-through-type passive avoidance test showed that mice were deficient in long-term memory (LTM) . From this observation, it is expected that drugs that modulate CREB function by enhancing cAMP signaling might yield an effective treatment for the memory defect (s) of Crebbp+/- mice. Actually Bourtchouladze et al. designed a cell-based drug screen and discovered inhibitors of phosphodiesterase 4 (PDE4) to be particularly effective enhancers of CREB function. They demonstrated that the inhibitor abolished the long-term memory defect of Crebbp+/- mice, suggesting that PDE4 inhibitors may be used to treat the cognitive dysfunction of RTS patients. Taken together, these results indicate that mouse models for human diseases are useful for functional genomic, medical genomics and pharmacogenomics.

Effets Cellulaires Et Moléculaires De L’invalidation Conditionnelle Du Gène MTR Au Niveau Du Foie Et Du Cerveau De Souris

Mutation in MTO1 involved in tRNA modification impairs mitochondrial RNA metabolism in the yeast Saccharomyces cerevisiae.

Mutations in MTO2 Related to Trna Modification Impair Mitochondrial Gene Expression and Protein Synthesis in the Presence of a Paromomycin Resistance Mutation in Mitochondrial 15 S Rrna

Identification and Characterization of Mouse MTO1 Gene Related to Mitochondrial Trna Modification.

Multilevel Functional and Structural Defects Induced by Two Pathogenic Mitochondrial Trna Mutations

Postnatal cerebellar defects in mice deficient in methylenetetrahydrofolate reductase

A transgenic mice model of retinopathy of cblG-type inherited disorder of one-carbon metabolism highlights epigenome-wide alterations related to cone photoreceptor cells development and retinal metabolism

Patho-Physiology of Myelin Deficient Mice

Cell-Type-Specific Gene Inactivation and in Situ Restoration Via Recombinase-Based Flipping of Targeted Genomic Region

TRMT10A dysfunction perturbs codon translation of initiator methionine and glutamine and impairs brain functions in mice

Cross-Talk between miRNAs from the Dlk1-Dio3 Locus and Histone Methylation to Protect Male Cerebellum from Methyl Donor Deficiency

A novel mouse model for genetic variation in 10-formyltetrahydrofolate synthetase exhibits disturbed purine synthesis with impacts on pregnancy and embryonic development

Expression De Protéines Protooncognes De La Superfamille Myc (C-Myc, Max, Mad1, Et Mxi1) Et De La Famille Bcl-2 (Bcl-2, Bax) Dans Les Chondrocytes Du Cartilage Épiphysaire Du Rat

In vivo dissection of the mouse tyrosine catabolic pathway with CRISPR-Cas9 identifies modifier genes affecting hereditary tyrosinemia type 1

EDTP/MTMR14: A novel target for improved survivorship to prolonged anoxia and cellular protein aggregates.

CMTR-1 RNA methyltransferase mutations activate widespread expression of a dopaminergic neuron-specific mitochondrial complex I gene

Metabolic Rewiring During Bone Development Underlies Trna M'g-Associated ' G-associated Primordial Dwarfism

La réactivation par translecture du gène p53 possédant une mutation non-sens induit l’apoptose de cellules cancéreuses

Age-related neurodegeneration and cognitive impairments of NRMT1 knockout mice are preceded by misregulation of RB and abnormal neural stem cell development

Development of a mouse model expressing a bifunctional glutathione-synthesizing enzyme to study glutathione limitation in vivo

Implementation of Anti-Apoptotic Peptide Aptamers in Cell and "in Vivo" Models of Parkinson's Disease